Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guoding Pharmaceutical, often referred to as Qingdao GD Biotechnology Pharmaceutical, is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-quality drug products. The company focuses on therapeutic areas such as metabolic diseases, particularly diabetes and obesity, as well as cardiovascular and gastrointestinal health. Guoding operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to produce both active pharmaceutical ingredients (APIs) and finished dosage forms. Their business model integrates R&D with large-scale production to serve both domestic and international markets. The company is recognized for its commitment to technological innovation in the synthesis of complex small molecules and peptide-based therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao GD Biotechnology Pharmaceutical.